NYC Hep B Coalition
NYC Hep C Task Force

Connect on LinkedIn

Subscribe to Posts


 

Subscribe to Posts


 

Mount Sinai Recanati/Miller Transplantation Institute HBV & HCV Clinical Trials

“The Mount Sinai Recanati/Miller Transplantation Institute is currently participating in several Hepatitis B and Hepatitis C clinical trials.  For more information about these clinical research opportunities, you may contact the Clinical Research Director by phone at 212-241-0255 or email at TXresearch@mountsinai.org

More Research Board Posts

2015 National Summit on HCV & HIV Diagnosis, Prevention & Access to Care: Abstracts, Presentations & Posters

June 17, 2015

    Abstracts, Presentations, and Posters are now Available Online Abstracts, presentations, and posters from the 2015 National Summit on HCV and HIV Diagnosis, Prevention and Access to Care are available on the Summit webpage. Final Program and Abstract Book (PDF) Program Overview and Plenary Presentations Breakout Session Presentations Posters More information on the 2015 National Summit is available at http://www.hivforum.org/2015Summit … Continue reading 2015 National Summit on HCV & HIV Diagnosis, Prevention & Access to Care: Abstracts, Presentations & Posters

read more »

Study | Incidence & prevalence of HCV among persons who inject drugs in NYC: 2006-2013

June 6, 2015

Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013. Drug Alcohol Depend. 2015.  HCV prevalence among PWID (N:1535) was 67% during the study period, and was not significantly different from that observed in 2000-2001. The estimated HCV incidence among new injectors (persons injecting for ≤6 years) … Continue reading Study | Incidence & prevalence of HCV among persons who inject drugs in NYC: 2006-2013

read more »

Study | A prospective evaluation of a community-based, multi-disciplinary, peer-driven model of Hep C treatment and support.

Beyond Viral Response: a prospective evaluation of a community-based, multi-disciplinary, peer-driven model of HCV treatment and support.  International Journal of Drug Policy, 2015.  Highlights We prospectively study a community-based hepatitis C (HCV) treatment program serving active drug users in Toronto, Canada. We examine HCV care outcomes and changes in psycho-social status, including social determinants of health … Continue reading Study | A prospective evaluation of a community-based, multi-disciplinary, peer-driven model of Hep C treatment and support.

read more »

EncephalApp | Smartphone app to identify hepatic encephalopathy in 5 mins

Up to 50% of cirrhosis patients are at risk for — or may already have — covert hepatic encephalopathy, whose symptoms are particularly hard to diagnose using a routine physical examination. In a researcher blog from DDW, Jasmohan S. Bajaj, MBBS, MD, MS, offers insight into his new smartphone application that can quickly identify patients … Continue reading EncephalApp | Smartphone app to identify hepatic encephalopathy in 5 mins

read more »

Study | An international perspective on using opioid substitution treatment (OST) to improve hep C prevention & care for people who inject drugs

June 5, 2015

An international perspective on using opioid substitution treatment (OST) to improve hepatitis C prevention and care for people who inject drugs: structural barriers and public health potential. International Journal of Drug Policy, 2015.  Highlights  We examined the use of mediation assisted treatment of opioid dependence to improve the HCV control. The stigmatization of drug use is … Continue reading Study | An international perspective on using opioid substitution treatment (OST) to improve hep C prevention & care for people who inject drugs

read more »

Hep C Provider Survey | Medscape & National Viral Hepatitis Roundtable (NVHR)

May 14, 2015

Hepatitis C Provider Survey HealthHCV, an advocacy and education initiative of HealthHIV, is launching its inaugural State of HCV Care national survey in partnership with Medscape. This survey will reach providers nationwide, specifically hepatologists, gastroenterologists, infectious disease specialists, HIV specialists, primary care providers, and others screening for and/or treating hepatitis C. Please help share this survey … Continue reading Hep C Provider Survey | Medscape & National Viral Hepatitis Roundtable (NVHR)

read more »